Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide (<sup>64</sup>Cu), a form of copper chloride (<sup>64</sup>CuCl<sub>2</sub>), is rapidly emerging as a diagnostic PET/CT tracer in oncology. It may also represent an in...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-12-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/1/223 |